Dr. Brian Chapman is an Associate Professor in the School of Computing and Information Systems at the University of Melbourne where he teaches subjects on the digital transformation of healthcare and machine learning applications for health. A native of the United States, he has lived in Australia since 2019. Dr. Chapman received a PhD in medical informatics from the University of Utah and has worked at the University of Pittsburgh, the University of California, San Diego, and the University of Utah before joining the University of Melbourne. His research has focused on extracting quantitative information from medical images and text. A survivor of two childhood cancers, Brian’s experiences as a patient have shaped his work as a teacher and a researcher.

Dr Amy Chan is Associate Professor and Respiratory lead of the Medicines Intelligence group at the School of Pharmacy, University of Auckland. She is a clinical pharmacist with over 15 years’ experience working in hospital, where she led one of the clinical pharmacy teams. Amy holds an honorary post with University College London, UK, where she completed her postdoctoral fellowship training. She now leads a research group that explores the intersection between digital technology, big data and respiratory health, with a focus on asthma outcomes. She is currently leading one of the working groups for the European Respiratory Society Clinical Research Collaboration CONNECT which focuses on digital respiratory healthcare, and is a global lead for workforce transformation with the International Pharmaceutical Federation (FIP).

Conjoint Professor Paul Robinson is the Deputy Director of the Children’s Health Environment Program within the Child Health Research Centre (CHRC), and Senior Staff Specialist in Respiratory and Sleep Medicine at the Queensland Children’s Hospital. His research program performs translational research outlining the role of peripheral airway function tests in early lung disease detection and ongoing monitoring of established disease. He has led the development and standardisation of novel measures of lung function across the entire age range from infancy onwards, facilitating the development of commercial equipment available for widespread use. His research focuses on defining the clinical utility of two specific peripheral airway function tests (Multiple breath washout, MBW, and oscillometry) in important obstructive lung diseases (e.g., asthma, cystic fibrosis, and post bone marrow transplant pulmonary graft vs host disease) and in understanding the impacts of environmental exposures. Structure-function relationships have been explored using state-of-the-art imaging techniques, with the aim of also developing new strategies to reduce any radiation exposure associated with these to advance incorporation into clinical care (e.g., ultra-low dose CT).

Zoe McKeough is an Associate Professor at the University of Sydney and managing director of the Better Breathing Foundation which raises funds to support research in chronic lung disease. Zoe has specialised in the area of pulmonary rehabilitation as a clinician, researcher and educator where her focus has been on identification of optimal modes of exercise training within pulmonary rehabilitation programs and the use of digital health technology for people with chronic lung diseases. Dr McKeough has over 100 papers published in international journals and has received over $5M of research funding.

Dr Wootton is a Clinical Specialist Physiotherapist in the Northern Sydney Local Health District Pulmonary and Heart Failure Rehabilitation program and is also an Honorary Senior Clinical Lecturer at The University of Sydney. Dr Wootton has specialised in the area of pulmonary rehabilitation with a particular interest in patients with COPD as a clinician, researcher and educator since 2004 and was awarded her PhD at The University of Sydney in 2016. Dr Wootton has extensive clinical and research experience in the area of pulmonary rehabilitation and is currently lead investigator on an RCT investigating the effectiveness of the first Australian specific mobile pulmonary rehabilitation platform.